突发性感音神经性聋复发与共病的全国性人群研究
利用2009至2020年韩国国民健康保险索赔数据库开展人群研究,纳入257,123例突发性感音神经性聋(SSNHL)患者,6.7%至少复发一次,复发率随复发次数增加和时间推移而上升,且随年龄增长而下降;复发患者中强直性脊柱炎发病率升高,2型糖尿病、心肌梗死和出血性卒中发病率降低。
要点
- SSNHL患者中6.7%(17,270/257,123)至少经历一次复发。
- 复发率随复发次数增加和时间推移上升,随年龄增长下降。
- 复发患者中强直性脊柱炎发病率升高,2型糖尿病、心肌梗死和出血性卒中发病率降低。
核心结论
- 对于复发或合并强直性脊柱炎的患者,应努力预防复发。
- SSNHL是耳科急症,症状出现时应立即接受治疗。
- 需要更多精心设计的人群研究来推广结果。
研究设计与样本
- 利用2009至2020年国民健康保险索赔数据库(NHICD)开展的人群研究。
- 仅纳入记录显示有类固醇处方、听力学检查结果及适当诊断编码的患者。
- SSNHL复发定义为首次发作后大于或等于3个月再次发生SSNHL。
主要发现
- 共识别257,123例患者,其中6.7%(17,270/257,123)至少复发一次。
- 每10万人发病率随年龄增长呈上升趋势,而复发率随年龄增长呈下降趋势。
- 复发患者中强直性脊柱炎(AS)发病率升高,2型糖尿病(T2DM)、心肌梗死(MI)和出血性卒中发病率降低。
临床怎么用
- 作者认为,对于复发或合并强直性脊柱炎的患者,应努力预防复发。
- 作者指出,SSNHL是耳科急症,症状出现时应立即接受治疗。
局限性
- 需要更多精心设计的人群研究来推广结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aims of this study were to investigate the cumulative recurrence rate of SSNHL and to determine association between comorbidities and recurrence of SSNHL by comparing patients with and without recurrence. METHODS: Using the National Health Insurance Claims Database (NHICD) from 2009 to 2020, we conducted a population-based study. We only enrolled patients whose records showed a prescription for steroid and audiometry findings as well as an appropriate diagnostic code. Recurrence of SSNHL was defined as an episode of SSNHL greater than or equal to 3 months after the first episode of SSNHL. We compared the recurrence rate of SSNHL according to age and number of SSNHL recurrences. We also explored comorbidities including autoimmune, metabolic, chronic renal diseases, cancer, and migraine associated with recurrent SSNHL. RESULTS: A total of 257,123 patients were identified. We found that 6.7% (17,270/257,123) of the patients had at least one recurrence of SSNHL. The recurrence rate increases with the number of recurrences and over time. The incidence per 100,000 people tended to increase with age, and the recurrence rate appeared to decrease with age. We found an increase in the incidence of ankylosing spondylitis (AS) and a decrease in the incidence of type 2 diabetes mellitus (T2DM), myocardial infarction (MI), and hemorrhagic stroke in patients with recurrence. CONCLUSION: For patients with recurrence or AS, considerable efforts should be made to prevent recurrence. As SSNHL is an emergent otologic condition, when symptoms occur, they should receive immediate treatment. Additional well-designed population-based studies are required to generalize our results. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:1417-1425, 2024.
引用
- Ko HY, Nam HJ, Kim MH, et al. A Nationwide Population-Based Study for the Recurrence and Comorbidities in Sudden Sensorineural Hearing Loss. Laryngoscope. 2023. PMID: 37737442. doi:10.1002/lary.31024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。